资助机构应促进产业界与学术界之间的合作关系。 - Suppr

Suppr

超能文献

Funding bodies should foster partnerships between industry and academia.

作者信息

Tzircotis George, Hickson Tony, Foulkes Iain

机构信息

Research & Innovation, Cancer Research UK, London, UK.

出版信息

Nat Rev Cancer. 2021 Feb;21(2):65-66. doi: 10.1038/s41568-020-00326-w.

DOI:10.1038/s41568-020-00326-w

PMID:33398101

Abstract

摘要

相似文献

Funding bodies should foster partnerships between industry and academia.

Nat Rev Cancer. 2021 Feb;21(2):65-66. doi: 10.1038/s41568-020-00326-w.

Funders must be wary of industry alliances.

Nature. 2018 Aug;560(7718):283. doi: 10.1038/d41586-018-05937-w.

Academia-pharma partnerships for novel drug discovery: essential or nice to have?

Expert Opin Drug Discov. 2017 Jun;12(6):537-540. doi: 10.1080/17460441.2017.1318124. Epub 2017 Apr 17.

US advisers seek research overhaul.

Nature. 2012 Dec 6;492(7427):18. doi: 10.1038/492018a.

Europe's innovation hub finally KICs off.

Nature. 2011 Feb 24;470(7335):450. doi: 10.1038/470450a.

[Development of synergies and partnerships on rare diseases: model of a scientific cooperation foundation].

Presse Med. 2012 May;41 Suppl 1:S23-5. doi: 10.1016/j.lpm.2012.02.029. Epub 2012 Apr 6.

Industry links boost research output.

Nature. 2017 Dec 7;552(7683):S11-S13. doi: 10.1038/d41586-017-07422-2.

The CNCCS, a benchmark Italian consortium for bioeconomy and an opportunity for the Istituto Superiore di Sanità.

Ann Ist Super Sanita. 2012;48(2):115-6. doi: 10.4415/ANN_12_02_01.

Institute doomed by loss of interest in basics.

Nature. 2004 Jul 15;430(6997):282. doi: 10.1038/430282a.

Building a new biomedical ecosystem: Pfizer's Centers for Therapeutic Innovation.

Clin Pharmacol Ther. 2013 Sep;94(3):314-6. doi: 10.1038/clpt.2013.89. Epub 2013 May 3.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Funding bodies should foster partnerships between industry and academia.

Nat Rev Cancer. 2021 Feb;21(2):65-66. doi: 10.1038/s41568-020-00326-w.

Funders must be wary of industry alliances.

Nature. 2018 Aug;560(7718):283. doi: 10.1038/d41586-018-05937-w.

Academia-pharma partnerships for novel drug discovery: essential or nice to have?

Expert Opin Drug Discov. 2017 Jun;12(6):537-540. doi: 10.1080/17460441.2017.1318124. Epub 2017 Apr 17.

US advisers seek research overhaul.

Nature. 2012 Dec 6;492(7427):18. doi: 10.1038/492018a.

Europe's innovation hub finally KICs off.

Nature. 2011 Feb 24;470(7335):450. doi: 10.1038/470450a.

[Development of synergies and partnerships on rare diseases: model of a scientific cooperation foundation].

Presse Med. 2012 May;41 Suppl 1:S23-5. doi: 10.1016/j.lpm.2012.02.029. Epub 2012 Apr 6.

Industry links boost research output.

Nature. 2017 Dec 7;552(7683):S11-S13. doi: 10.1038/d41586-017-07422-2.

The CNCCS, a benchmark Italian consortium for bioeconomy and an opportunity for the Istituto Superiore di Sanità.

Ann Ist Super Sanita. 2012;48(2):115-6. doi: 10.4415/ANN_12_02_01.

Institute doomed by loss of interest in basics.

Nature. 2004 Jul 15;430(6997):282. doi: 10.1038/430282a.

Building a new biomedical ecosystem: Pfizer's Centers for Therapeutic Innovation.

Clin Pharmacol Ther. 2013 Sep;94(3):314-6. doi: 10.1038/clpt.2013.89. Epub 2013 May 3.